Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:46 pm Sale | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Armistice Capital, LLC | 1,536,000 4.940% | -64,000 (-4.00%) | Filing History |
| 2026-02-17 9:53 pm Unchanged | 2025-12-31 | 13G | AngioDynamics, Inc. ANGO | Armistice Capital, LLC | 1,624,000 6.000% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:40 pm Sale | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | K2 HealthVentures Equity Trust LLC | 788,995 2.400% | -828,860 (-51.23%) | Filing History |
| 2026-02-17 4:30 pm Purchase | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Point72 Asset Management, L.P. | 2,824,275 8.900% | 916,444 (+48.04%) | Filing History |
| 2026-02-17 4:13 pm Purchase | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Commodore Capital LP | 3,245,628 9.900% | 55,361 (+1.74%) | Filing History |
| 2026-02-17 4:05 pm Purchase | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Vestal Point Capital, LP | 2,485,000 8.000% | 2,485,000 (New Position) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Perceptive Advisors LLC | 3,249,934 9.990% | 1,260,541 (+63.36%) | Filing History |
| 2025-10-27 4:02 pm Purchase | 2025-10-20 | 13G | Alto Neuroscience, Inc. ANRO | Commodore Capital LP | 3,190,267 9.800% | 3,190,267 (New Position) | Filing History |
| 2025-10-10 12:50 pm Purchase | 2025-10-03 | 13G | Alto Neuroscience, Inc. ANRO | Perceptive Advisors LLC | 1,989,393 7.300% | 1,989,393 (New Position) | Filing History |
| 2025-08-14 9:36 pm Purchase | 2025-06-30 | 13G | AngioDynamics, Inc. ANGO | Armistice Capital, LLC | 1,624,000 6.000% | 1,624,000 (New Position) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Alto Neuroscience, Inc. ANRO | BlackRock Inc. BLK | 561,363 2.100% | -884,371 (-61.17%) | Filing History |
| 2025-05-15 4:26 pm Sale | 2025-03-31 | 13G | Alto Neuroscience, Inc. ANRO | Point72 Asset Management, L.P. | 1,907,831 7.000% | -452,100 (-19.16%) | Filing History |
| 2025-05-15 3:19 pm Purchase | 2025-01-13 | 13G | Alto Neuroscience, Inc. ANRO | K2 HealthVentures Equity Trust LLC | 1,617,855 5.600% | 1,617,855 (New Position) | Filing History |
| 2025-05-15 3:05 pm Purchase | 2025-03-31 | 13G | Alto Neuroscience, Inc. ANRO | Armistice Capital, LLC | 1,600,000 5.910% | 1,600,000 (New Position) | Filing History |
| 2025-02-14 6:26 pm Sale | 2024-12-31 | 13G | Alto Neuroscience, Inc. ANRO | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,075,154 (Position Closed) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Point72 Asset Management, L.P. | 2,359,931 8.800% | 667,153 (+39.41%) | Filing History |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Alto Neuroscience, Inc. ANRO | FMR LLC | 1,265,546 4.700% | -1,097,510 (-46.44%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Alto Neuroscience, Inc. ANRO | RA CAPITAL MANAGEMENT L.P. | 2,075,154 7.700% | 689,663 (+49.78%) | Filing History |
| 2024-11-14 07:00 am Purchase | 2024-09-30 | 13G | Alto Neuroscience, Inc. ANRO | Etkin Amit | 1,461,130 5.400% | 1,461,130 (New Position) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Alto Neuroscience, Inc. ANRO | FMR LLC | 2,363,056 8.765% | 2,363,056 (New Position) | Filing History |